Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
Conducting a successful clinical trial is by no means an easy endeavor; it requires extensive…
Circulating tumor cell counts are powerful prognostic factors for cancer patients. Recent research has found…
The EU’s clinical trial regulations received a major overhaul at the end of January 2022…
The role of biostatisticians goes far beyond analyzing data at the end of a clinical…
Conducting clinical trials on time ensures that innovative treatments can reach patients in need. In…
How can we make clinical trial recruitment more reflective of the real world? Technology is…
Last week, the French vaccine maker Valneva announced promising phase III trial results of its…
Johnson & Johnson became the latest company to have a failed vaccine trial against HIV…
An Alzheimer’s disease drug developed by AC Immune and Genentech has drawn conflicting phase II…
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…